Published in Blood Weekly, March 31st, 1997
The agreement with Fresenius AG, Bad Homburg, Germany, provides for the development and commercialization of transgenic human serum albumin. Albumin is the most important protein involved in maintaining the balance of fluids in the blood.
Albumin regulates the transport of amino acids, fatty acids, hormones, drugs, and drug metabolites. Clinical uses include blood volume replacement during conditions of shock, serious burns, and other emergency medicine; during AIDS and cancer therapies; and during...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.